Under an ‘America First’ president, will the U.S. corner the market on Covid-19 vaccine?
The United States is sprinting headlong toward the development and distribution of Covid-19 vaccines. But under an “America First” president, public health experts worry, the United States could seek to gobble up early supplies — and set the stage for prolonged devastation in the rest of the world.
Under “Operation Warp Speed,” the Trump administration hopes to have 300 million doses of vaccine ready for domestic use by January 2021. That outcome would largely satisfy domestic needs in the United States, experts say, but it would mean prioritizing low-risk individuals in one the world’s richest countries over high-risk health care workers and other vulnerable populations elsewhere in the world.
